“Without alternative income, formal social protection systems or savings to buffer these shocks, workers and their families will be pushed into poverty, reversing decades of poverty reduction.”
The region-wide economy was expected to contract by 0.4 per cent in 2020, it said, while remittances from Southeast Asians working abroad were likely to fall by 13 per cent or $10 billion.

Gilead raises sales outlook to include COVID-19 treatment remdesivir

Jul 31, 2020

Demand for remdesivir continues to outstrip supply in many parts of the world.

Gilead’s chief executive, Daniel O’Day, on a conference call, said the company expects by the end of September to be producing enough remdesivir to meet real-time global demand.

Gilead said it still expects to manufacturer 2 million or more remdesivir treatment courses cumulatively in 2020, and its revenue outlook reflects expected sales of up to 1.5 million courses this year.

Global health agencies fear wealthier countries will go it alone on Covid-19 vaccines

Jul 30, 2020

“There is a risk that some countries are doing exactly what we feared – which is every man for himself,” said Gayle Smith, former head of the US Agency for International Development and CEO of the One Campaign, a non-profit aimed at ending poverty and preventable disease.

Swiss Re reshuffles APAC management team

Jul 30, 2020

According to a Swiss Re announcement on Thursday, Sharon Ooi,currently managing director, head of P&C underwriting APAC, based in Singapore will relocate to Sydney to become head of Australia and New Zealand,

Sharon will replace Mark Senkevics who in turn will take charge of Ooi’s current role and lead Swiss Re’s APAC property and casualty (P&C) underwriting business from Sydney,

« Older Entries

Next Entries »

Briefs